MGC Diagnostics Corporation
MGCD
MGCD was delisted on the 28th of December, 2017.
15 hedge funds and large institutions have $4.76M invested in MGC Diagnostics Corporation in 2015 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
6% less funds holding
Funds holding: 16 → 15 (-1)
30% less capital invested
Capital invested by funds: $6.76M → $4.76M (-$2M)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.99K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.76K |
| 3 |
PCM
Prelude Capital Management
New York
|
+$3.11K |
| 4 |
Renaissance Technologies
New York
|
+$3.11K |
| 5 |
UMA
USA Mutuals Advisors
Dallas,
Texas
|
+$1.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LBIM
Land & Buildings Investment Management
Stamford,
Connecticut
|
-$392K |
| 2 |
IM
ISF Management
New York
|
-$18.6K |
| 3 |
Morgan Stanley
New York
|
-$13.8K |
| 4 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
-$5K |
| 5 |
Bank of New York Mellon
New York
|
-$4.03K |
MGCD Hedge Fund Activity: Q2 2015 in Review
15 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in MGC Diagnostics Corporation (MGCD) for Q2 2015, worth a combined $4.76M — down 30% from $6.76M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of MGCD and 1 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 4 added.
The largest buyer was Tower Research Capital (TRC), adding an estimated $7.99K. The largest seller was Land & Buildings Investment Management, exiting entirely with an estimated $392K sold.
- 15 institutional investors held MGC Diagnostics Corporation (MGCD) as of Q2 2015, down from 16 in Q1 2015.
- Funds reported $4.76M of MGC Diagnostics Corporation stock for Q2 2015, down 30% quarter-over-quarter.
- 1 fund opened new MGC Diagnostics Corporation positions in Q2 2015 and 2 closed out, a net change of -1 holder.
- The largest MGC Diagnostics Corporation buyer in Q2 2015 was Tower Research Capital (TRC), an estimated $7.99K added.
- The largest MGC Diagnostics Corporation seller in Q2 2015 was Land & Buildings Investment Management, an estimated $392K sold.
Based on aggregated 13F filings for Q2 2015.